Effect of Hemodialysis on the PK of JTZ-951 in Subjects With End-stage Renal Disease

Summary

The purpose of this study is to evaluate the effect of hemodialysis on the pharmacokinetics (PK) of JTZ-951 and to evaluate the safety of 2 doses of JTZ-951 in subjects with end-stage renal disease (ESRD) receiving hemodialysis

Timeline

Start

2013-10

Primary completion

2013-12

Completion

2014-01

Drugs

Indications